| 000 | 01063 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515162854.0 | ||
| 264 | 0 | _c20090424 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/STROKEAHA.108.520684 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDonnan, Geoffrey A | |
| 245 | 0 | 0 |
_aThe ethics of thrombolytic trials beyond 3 (or 4.5) hours: randomized controlled trials are required to change clinical practice. _h[electronic resource] |
| 260 |
_bStroke _cApr 2009 |
||
| 300 |
_a1545 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aClinical Trials, Phase III as Topic _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xmethods |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 650 | 0 | 4 |
_aThrombolytic Therapy _xethics |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aDavis, Stephen M | |
| 773 | 0 |
_tStroke _gvol. 40 _gno. 4 _gp. 1545 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/STROKEAHA.108.520684 _zAvailable from publisher's website |
| 999 |
_c18725667 _d18725667 |
||